Saulenas A M, Cohen S M, Key L L, Winter C, Albert D M
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.
Arch Ophthalmol. 1988 Apr;106(4):533-5. doi: 10.1001/archopht.1988.01060130579041.
The vitamin D receptor has been found in several human organs not involved in calcium metabolism and in several malignant neoplasms found in humans. The role of the receptor in these tissues is unclear. There is, however, a relationship between the presence and quantity of the vitamin D receptor in a malignant cell line and the antineoplastic effect of vitamin D on that cell line. We found that Y-79 retinoblastoma cells have receptors specific for calcitriol (1,25-dihydroxycholecalciferol). Scatchard analysis of the receptor data shows a quantity of 56,000 receptors per retinoblastoma cell. These receptors have a dissociation constant of 1.18 nmol/L. Retinoblastoma cells treated with 10(-9) mol/L of calcitriol for nine days had 15% less cell growth than the control cells. Further studies of the effect of vitamin D on retinoblastoma may warrant its inclusion in chemotherapeutic protocols for the treatment of this childhood affliction.
维生素D受体已在人体中一些不参与钙代谢的器官以及几种人类恶性肿瘤中被发现。该受体在这些组织中的作用尚不清楚。然而,恶性细胞系中维生素D受体的存在和数量与维生素D对该细胞系的抗肿瘤作用之间存在关联。我们发现Y-79视网膜母细胞瘤细胞具有对骨化三醇(1,25-二羟基胆钙化醇)特异的受体。对受体数据进行Scatchard分析显示,每个视网膜母细胞瘤细胞有56,000个受体。这些受体的解离常数为1.18 nmol/L。用10(-9) mol/L骨化三醇处理9天的视网膜母细胞瘤细胞的生长比对照细胞少15%。对维生素D对视网膜母细胞瘤影响的进一步研究可能使其有必要被纳入治疗这种儿童疾病的化疗方案中。